Q&A Clinic on post-authorisation procedure management in IRIS - 8 Jan 2025, Online, from 8 January 2025, 14:00 (CET) to 8 January 2025, 15:00 (CET)
Human medicines European public assessment report (EPAR): Durysta, bimatoprost, Status: Withdrawn application (before opinion)
Big Data Steering Group (BDSG): 2024 report
FAQs: How to create, submit and withdraw a Clinical Trial Application - CTIS Training Programme - Module 10
Medroxyprogesterone acetate
Human medicines European public assessment report (EPAR): Naglazyme, galsulfase, Date of authorisation: 23/01/2006, Revision: 20, Status: Authorised
Organisation chart: Information Management
Successful pilot paves the way for implementation of ePI
Electronic product information (ePI) report: Experience gained from creation of ePI during regulatory procedures for EU human medicines
Union list of critical medicines - version 2